LAROCCA, Alessandra
LAROCCA, Alessandra
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma
2016-01-01 Larocca, A.; Bringhen, S.; Petrucci, M.T.; Oliva, S.; Falcone, A.P.; Caravita, T.; Villani, O.; Benevolo, G.; Liberati, A.M.; Morabito, F.; Montefusco, V.; Passera, R.; De Rosa, L.; Omedé, P.; Vincelli, I.D.; Spada, S.; Carella, A.M.; Ponticelli, E.; Derudas, D.; Genuardi, M.; Guglielmelli, T.; Nozzoli, C.; Aghemo, E.; De Paoli, L.; Conticello, C.; Musolino, C.; Offidani, M.; Boccadoro, M.; Sonneveld, P.; Palumbo, A
A PHASE III STUDY OF ENOXAPARIN VS ASPIRIN AS THROMBOPROPHYLAXIS FOR PATIENTS WITH NEWLY DIAGNOSED OF MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE-BASED REGIMENS.
2011-01-01 F. CAVALLO; T. CARAVITA; F. DI RAIMONDO; G. CICCONE; B. LUPO; M. MARCATTI; A. BARALDI; N. PESCOSTA; A.P. FALCONE ;R. RIA; L. BALDINI; L. MASINI; T. GUGLIELMELLI; G. GAIDANO; G. BENEVOLO; C. CANGIALOSI ; M. GALLI ; L. CATALANO; A. LAROCCA; A. NAGLER; M. BOCCADORO; A. PALUMBO
A PROSPECTIVE RANDOMIZED TRIAL OF BORTEZOMIB-MELPHALANPREDNISONE-THALIDOMIDE FOLLOWED BY CONTINUOUS BORTEZOMIB-THALIDOMIDE FOR INITIAL THERAPY OF MULTIPLE MYELOMA:EFFECT OF AGE AND CO-MORBIDITIES
2010-01-01 A Palumbo; S Bringhen; D Rossi; M Cavalli; R Ria; M Offidani; C Nozzoli; L Baldini; L De Rosa; G De Sabbata; AM Liberati; C Crippa; F Ciambelli; V Callea; M Spriano; F Ferrara; F Elice; M Galli; J Peccatori; L Catalano; M Rizzo; R Marasca; F Pisani; M Cavo; M Petrucci; P Musto; P Omedè; A Larocca; G Gaidano; M Boccadoro
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia.
2005-01-01 Rossini F;Terruzzi E;Verga L;Larocca A;Marinoni S;Miccolis I;Giltri G;Isella M;Parma M;Pogliani EM
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients
2013-01-01 Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A
ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS
2010-01-01 F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
2022-01-01 Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, María-Victoria; Špička, Ivan; Lazaroiu, Mihaela; Berdeja, Jesús; Kaufman, Jonathan L; Jou, Ying-Ming; Ganetsky, Alex; Popa McKiver, Mihaela; Lonial, Sagar; Weisel, Katja; Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, María-Victoria; Špička, Ivan; Lazaroiu, Mihaela; Berdeja, Jesús; Kaufman, Jonathan L; Jou, Ying-Ming; Ganetsky, Alex; Popa McKiver, Mihaela; Lonial, Sagar; Weisel, Katja; Sandhu, Irwindeep; Podhorecka, Monika; Palumbo, Antonio; Shacham-Abulafia, Adi; Vaxman, Iuliana; Shpilberg, Ofer; Besemer, Britta; Martelli, Maurizio; Foà, Roberto; De Fabritiis, Paolo; Caravita di Toritto, Tommaso; Gheorghita, Emanuil; Oriol, Albert; Rowlings, Philip; Emanuele, Angelucci; Carella, Angelo M; Offidani, Massimo; Bladé, Joan; Casado, Luis F; Oakervee, Heather; Panelli, Victoria; Meza, Luis; Kühr, Thomas; Granell, Miguel; Benson, Don; Nair, Rajesh; Holden, Viran; Reeves, James; Eek, Richard W; Walker, Patricia A; Catalano, John; Rosta, András; Lech-Marańda, Ewa; Samaras, Christy; Reiman, Anthony; Weaver, Robert; Acs, Peter; Grigg, Andrew; De Prijck, Bernard; Louzada, Martha; Minuk, Leonard; Sebag, Michael; Klausmann, Martine; Welslau, Manfred; Hellmann, Andrzej; Danaila, Catalin; Becker, Pamela; Bensinger, William; Porterfield, Bruce; Modiano, Manuel; Schultz, Stephen M; Manges, Robert; Lee, Huey-Shin Cindy; Gray, James X; Wright, Matthew P; Vekemans, Marie-Christine; Hamed, Aryan; Gasztonyi, Zoltán; Mikala, Gábor; Masszi, Tamás; Gamberi, Barbara; Kuliczkowski, Kazimierz; Usnarska-Zubkiewicz, Lidia; Bengoechea, Enrique; Gutiérrez, María AE; García, Miguel TH; San-Miguel, Jesús; Driessen, Christoph; Behl, Rajesh; Brenner, Warren; Gray, Carl; Hansen, Vincent; Moezi, Mehdi; Cortes, Hector V; Yen, Charles; Gressot, Laurent; Horvath, Noemi; D'Rozario, James M; Latimer, Maya; Kyrtsonis, Maria-Christine; Chubar, Evgeni; Mittelman, Moshe; Baldini, Luca; Tosi, Patrizia; Vacca, Angelo; Jędrzejczak, Wiesław W; Robak, Tadeusz; Lahuerta, Juan J; Carney, Jennifer; Chen, Franklin; Hirsch, Robert; Ruiz, Marco; Alencar, Alvaro; Jagasia, Madan; Kasbari, Samer; Kuriakose, Philip; Mahmood, Aftab; Chaudhry, Madhu; Cohen, Gary; Noga, Stephen; Roa, Sch; Jakubowiak, Andrzej; Rosenbaum, Cara; Delforge, Michel; Delrieu, Vanessa; Doyen, Chantal; Dries, Deeren; Demuynck, Hilde; Schots, Rik; Maisnar, Vladimir; Blau, Igor W; Dürk, Heinz A; Kerkhoff, Andrea; Kropff, Martin; Munder, Markus; Röllig, Christoph; Scheid, Christof; Symeonidis, Argiris S; Illés, Árpád; Coyne, Mark; O'Gorman, Peter; Hayden, Patrick; O'Dwyer, Michael; Ben-Yehuda, Dina; Braester, Andrei; Nemets, Anatoly; Lugassy, Gilles; Cohen, Yossi; Rahimi-Levene, Naomi; Bosi, Alberto; Pezzatti, Sara; Rossini, Fausto; Pogliani, Enrico M; Pinto, Antonello; Komarnicki, Mieczysław; Borsaru, Gabriela; Stoia, Razvan; Afanasyev, Boris; Goñi, María A; Carboneras, Ana V; Ali, Sarah; Rubenstein, S. Eric; Caputto, Salvador; Cosgriff, Thomas; Fanning, Suzanne; Khojasteh, Ali; Liman, Andrew; Malcolm, Albert; Vrindavanam, Nandagopal; Patel, Ravindranath; Belani, Rajesh; Shieh, Marie; Stockerl-Goldstein, Keith; Strnad, Charles; Stuart, Robert; Chhabra, Saurabh; Costa, Luciano; Jhangiani, Haresh; Augustson, Bradley; Filshie, Robin; Johnston, Amanda; Hertzberg, Mark S; Mineur, Philippe; Fox, Susan; Kotb, Rami; Dao, Vi; LeBlanc, Richard; Gregora, Evzen; Brioli, Annamaria; Mügge, Lars-Olof; Hänel, Mathias; Langer, Christian; Kapsali, Eleni; Briasoulis, Evangelos; Kyriakou, Despoina; Hardan, Izhar; Horowitz, Netanel A; Clotilde, Cangialosi; Fabbiano, Francesco; Castagnari, Barbara; Ciceri, Fabio; Musuraca, Gerardo; Deptała, Andrzej; Kłoczko, Janusz; Balea, Marius; Vladareanu, Ana-Maria; Rossiev, Victor; Alegre, Adrián; Encinas, Cristina; Gayoso, Jorge; Pabst, Thomas; Rabin, Neil; Arledge, Sherri; Cabanillas, Fernando; Catlett, Joseph; Chidiac, Tarek; Clarkson, David; Dhodapkar, Madhav; Geils, George; Khan, Cyrus MA; Sahovic, Entezam; Khasawneh, Mohamad; Sehgal, Rajesh; Ballester, Oscar; Levy, Moshe; Fay, Joseph; Liem, Kiem; Lunning, Matthew; Vose, Julie; Faber, Edward; MacFarlane, Donald; Hohl, Raymond; Mahmood, Tariq; Bhaskar, Birbal; Mims, Martha; Oliff, Ira; Paner, Agne; Maciejewski, John; Padmanabhan, Arvinda; Richard, Robert; Sanyal, Amit; Schiller, Gary; Staszewski, Harry; Stevens, Don; Vaughn, Christopher; Windsor, Kevin
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials
2013-01-01 Bringhen S;Mateos MV;Zweegman S;Larocca A;Falcone AP;Oriol A;Rossi D;Cavalli M;Wijermans P;Ria R;Offidani M;Lahuerta JJ;Liberati AM;Mina R;Callea V;Schaafsma M;Cerrato C;Marasca R;Franceschini L;Evangelista A;Teruel AI;van der Holt B;Montefusco V;Ciccone G;Boccadoro M;San Miguel J;Sonneveld P;Palumbo A
Aspirin or enoxaparin thromboprophylaxis for newly-diagnosed multiple myeloma patients treated with lenalidomide
2012-01-01 Larocca A; Cavallo F; Bringhen S; Di Raimondo F; Falanga A; Evangelista A; Cavalli M; Stanevsky A; Corradini P; Pezzati S; Patriarca F; Cavo M; Peccatori J; Catalano L; Carella AM; Cafro AM; Siniscalchi A; Crippa C; Petrucci MT; Ben Yehuda D; Beggiato E; Caravita Di Toritto T; Boccadoro M; Nagler A; Palumbo A
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study
2022-01-01 Efficace, Fabio; Gaidano, Gianluca; Petrucci, Maria Teresa; Niscola, Pasquale; Cottone, Francesco; Codeluppi, Katia; Antonioli, Elisabetta; Tafuri, Agostino; Larocca, Alessandra; Potenza, Leonardo; Fozza, Claudio; Pastore, Domenico; Rigolin, Gian Matteo; Offidani, Massimo; Romano, Alessandra; Kyriakou, Charalampia; Cascavilla, Nicola; Gozzetti, Alessandro; Derudas, Daniele; Vignetti, Marco; Cavo, Michele
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
2006-01-01 Larocca A;Piaggio G;Podestà M;Pitto A;Bruno B;Di Grazia C;Gualandi F;Occhini D;Raiola AM;Dominietto A;Bregante S;Lamparelli T;Tedone E;Oneto R;Frassoni F;Van Lint MT;Pogliani E;Bacigalupo A
Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy.
2014-01-01 Mateos MV;Bringhen S;Richardson PG;Lahuerta JJ;Larocca A;Oriol A;Boccadoro M;García-Sanz R;Di Raimondo F;Esseltine DL;van de Velde H;Desai A;Londhe A;San Miguel JF;Palumbo A
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: A multicenter, open label phase 1/2 study.
2012-01-01 Petrucci MT; Levi A; Bringhen S; Scotti S; Gentilini F; Russo S; Siniscalchi A; Larocca A; Grammatico S; Boccadoro M; Foà R; Palumbo A.
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: a multicenter, open label phase 1/2 study.
2013-01-01 Petrucci MT;Levi A;Bringhen S;Scotti S;Gentilini F;Russo S;Siniscalchi A;Larocca A;Grammatico S;Boccadoro M;Foà R;Palumbo A
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.
2014-01-01 Morabito F;Bringhen S;Larocca A;Wijermans P;Mateos M V;Gimsing P;Mazzone C;Gottardi D;Omedè P;Zweegman S;Lahuerta J J;Zambello R;Musto P;Magarotto V;Schaafsma M;Oriol A;Juliusson G;Cerrato C;Catalano L;Gentile M;Turel A I;Liberati A M;Cavalli M;Rossi D;Passera R;Rosso S;Beksac M;Cavo M;Waage A;San-Miguel J;Boccadoro M;Sonneveld P;Palumbo A;Offidani M
Bortezomib, Pegylated-Lyposomal-Doxorubicin and Dexamethasone Followed by Melphalan 100 mg/m2 in Elderly Newly Diagnosed Patients: An Interim Analysis.
2007-01-01 Palumbo A; Avonto I; Patriarca F; Crippa C; Petrucci MT; Rossini F; Corradini P; Liberati AM; Giuliani N; Pescosta N; Falco P; Larocca A; Omedè P; Offidani M; Fanin R; Boccadoro M
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study
2020-01-01 Mina R.; Belotti A.; Petrucci M.T.; Zambello R.; Capra A.; Di Lullo G.; Ronconi S.; Pescosta N.; Grasso M.; Monaco F.; Cellini C.; Gobbi M.; Ballanti S.; de Fabritiis P.; Mosca-Siez M.L.; Marchetti M.; Liberati A.M.; Offidani M.; Giuliani N.; Ria R.; Musto P.; Romano A.; Sonneveld P.; Boccadoro M.; Larocca A.
Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial.
2010-01-01 Palumbo A; Bringhen S; Rossi D; Cavalli M; Larocca A; Ria R; Offidani M; Patriarca F; Nozzoli C; Guglielmelli T; Benevolo G; Callea V; Baldini L; Morabito F; Grasso M; Leonardi G; Rizzo M; Pia Falcone A; Gottardi D; Montefusco V; Musto P; Petrucci MT; Ciccone G; Boccadoro M.
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.
2014-01-01 Palumbo A;Bringhen S;Larocca A;Rossi D;Di Raimondo F;Magarotto V;Patriarca F;Levi A;Benevolo G;Vincelli ID;Grasso M;Franceschini L;Gottardi D;Zambello R;Montefusco V;Falcone AP;Omedé P;Marasca R;Morabito F;Mina R;Guglielmelli T;Nozzoli C;Passera R;Gaidano G;Offidani M;Ria R;Petrucci MT;Musto P;Boccadoro M;Cavo M
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)
2018-01-01 Sara Bringhen, Alberto Milan, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Marco Salvini, Evangelos Terpos, Hartmut Goldschmidt, Michele Cavo, Maria Teresa Petrucci, Heinz Ludwig, Holger W. Auner, Jo Caers, Martin Gramatzki, Mario Boccadoro, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma | 2016 | Larocca, A.; Bringhen, S.; Petrucci, M.T.; Oliva, S.; Falcone, A.P.; Caravita, T.; Villani, O.; Benevolo, G.; Liberati, A.M.; Morabito, F.; Montefusco, V.; Passera, R.; De Rosa, L.; Omedé, P.; Vincelli, I.D.; Spada, S.; Carella, A.M.; Ponticelli, E.; Derudas, D.; Genuardi, M.; Guglielmelli, T.; Nozzoli, C.; Aghemo, E.; De Paoli, L.; Conticello, C.; Musolino, C.; Offidani, M.; Boccadoro, M.; Sonneveld, P.; Palumbo, A | |
| A PHASE III STUDY OF ENOXAPARIN VS ASPIRIN AS THROMBOPROPHYLAXIS FOR PATIENTS WITH NEWLY DIAGNOSED OF MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE-BASED REGIMENS. | 2011 | F. CAVALLO; T. CARAVITA; F. DI RAIMONDO; G. CICCONE; B. LUPO; M. MARCATTI; A. BARALDI; N. PESCOSTA; A.P. FALCONE ;R. RIA; L. BALDINI; L. MASINI; T. GUGLIELMELLI; G. GAIDANO; G. BENEVOLO; C. CANGIALOSI ; M. GALLI ; L. CATALANO; A. LAROCCA; A. NAGLER; M. BOCCADORO; A. PALUMBO | |
| A PROSPECTIVE RANDOMIZED TRIAL OF BORTEZOMIB-MELPHALANPREDNISONE-THALIDOMIDE FOLLOWED BY CONTINUOUS BORTEZOMIB-THALIDOMIDE FOR INITIAL THERAPY OF MULTIPLE MYELOMA:EFFECT OF AGE AND CO-MORBIDITIES | 2010 | A Palumbo; S Bringhen; D Rossi; M Cavalli; R Ria; M Offidani; C Nozzoli; L Baldini; L De Rosa; G De Sabbata; AM Liberati; C Crippa; F Ciambelli; V Callea; M Spriano; F Ferrara; F Elice; M Galli; J Peccatori; L Catalano; M Rizzo; R Marasca; F Pisani; M Cavo; M Petrucci; P Musto; P Omedè; A Larocca; G Gaidano; M Boccadoro | |
| A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia. | 2005 | Rossini F;Terruzzi E;Verga L;Larocca A;Marinoni S;Miccolis I;Giltri G;Isella M;Parma M;Pogliani EM | |
| A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients | 2013 | Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A | |
| ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS | 2010 | F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo | |
| Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial | 2022 | Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, María-Victoria; Špička, Ivan; Lazaroiu, Mihaela; Berdeja, Jesús; Kaufman, Jonathan L; Jou, Ying-Ming; Ganetsky, Alex; Popa McKiver, Mihaela; Lonial, Sagar; Weisel, Katja; Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, María-Victoria; Špička, Ivan; Lazaroiu, Mihaela; Berdeja, Jesús; Kaufman, Jonathan L; Jou, Ying-Ming; Ganetsky, Alex; Popa McKiver, Mihaela; Lonial, Sagar; Weisel, Katja; Sandhu, Irwindeep; Podhorecka, Monika; Palumbo, Antonio; Shacham-Abulafia, Adi; Vaxman, Iuliana; Shpilberg, Ofer; Besemer, Britta; Martelli, Maurizio; Foà, Roberto; De Fabritiis, Paolo; Caravita di Toritto, Tommaso; Gheorghita, Emanuil; Oriol, Albert; Rowlings, Philip; Emanuele, Angelucci; Carella, Angelo M; Offidani, Massimo; Bladé, Joan; Casado, Luis F; Oakervee, Heather; Panelli, Victoria; Meza, Luis; Kühr, Thomas; Granell, Miguel; Benson, Don; Nair, Rajesh; Holden, Viran; Reeves, James; Eek, Richard W; Walker, Patricia A; Catalano, John; Rosta, András; Lech-Marańda, Ewa; Samaras, Christy; Reiman, Anthony; Weaver, Robert; Acs, Peter; Grigg, Andrew; De Prijck, Bernard; Louzada, Martha; Minuk, Leonard; Sebag, Michael; Klausmann, Martine; Welslau, Manfred; Hellmann, Andrzej; Danaila, Catalin; Becker, Pamela; Bensinger, William; Porterfield, Bruce; Modiano, Manuel; Schultz, Stephen M; Manges, Robert; Lee, Huey-Shin Cindy; Gray, James X; Wright, Matthew P; Vekemans, Marie-Christine; Hamed, Aryan; Gasztonyi, Zoltán; Mikala, Gábor; Masszi, Tamás; Gamberi, Barbara; Kuliczkowski, Kazimierz; Usnarska-Zubkiewicz, Lidia; Bengoechea, Enrique; Gutiérrez, María AE; García, Miguel TH; San-Miguel, Jesús; Driessen, Christoph; Behl, Rajesh; Brenner, Warren; Gray, Carl; Hansen, Vincent; Moezi, Mehdi; Cortes, Hector V; Yen, Charles; Gressot, Laurent; Horvath, Noemi; D'Rozario, James M; Latimer, Maya; Kyrtsonis, Maria-Christine; Chubar, Evgeni; Mittelman, Moshe; Baldini, Luca; Tosi, Patrizia; Vacca, Angelo; Jędrzejczak, Wiesław W; Robak, Tadeusz; Lahuerta, Juan J; Carney, Jennifer; Chen, Franklin; Hirsch, Robert; Ruiz, Marco; Alencar, Alvaro; Jagasia, Madan; Kasbari, Samer; Kuriakose, Philip; Mahmood, Aftab; Chaudhry, Madhu; Cohen, Gary; Noga, Stephen; Roa, Sch; Jakubowiak, Andrzej; Rosenbaum, Cara; Delforge, Michel; Delrieu, Vanessa; Doyen, Chantal; Dries, Deeren; Demuynck, Hilde; Schots, Rik; Maisnar, Vladimir; Blau, Igor W; Dürk, Heinz A; Kerkhoff, Andrea; Kropff, Martin; Munder, Markus; Röllig, Christoph; Scheid, Christof; Symeonidis, Argiris S; Illés, Árpád; Coyne, Mark; O'Gorman, Peter; Hayden, Patrick; O'Dwyer, Michael; Ben-Yehuda, Dina; Braester, Andrei; Nemets, Anatoly; Lugassy, Gilles; Cohen, Yossi; Rahimi-Levene, Naomi; Bosi, Alberto; Pezzatti, Sara; Rossini, Fausto; Pogliani, Enrico M; Pinto, Antonello; Komarnicki, Mieczysław; Borsaru, Gabriela; Stoia, Razvan; Afanasyev, Boris; Goñi, María A; Carboneras, Ana V; Ali, Sarah; Rubenstein, S. Eric; Caputto, Salvador; Cosgriff, Thomas; Fanning, Suzanne; Khojasteh, Ali; Liman, Andrew; Malcolm, Albert; Vrindavanam, Nandagopal; Patel, Ravindranath; Belani, Rajesh; Shieh, Marie; Stockerl-Goldstein, Keith; Strnad, Charles; Stuart, Robert; Chhabra, Saurabh; Costa, Luciano; Jhangiani, Haresh; Augustson, Bradley; Filshie, Robin; Johnston, Amanda; Hertzberg, Mark S; Mineur, Philippe; Fox, Susan; Kotb, Rami; Dao, Vi; LeBlanc, Richard; Gregora, Evzen; Brioli, Annamaria; Mügge, Lars-Olof; Hänel, Mathias; Langer, Christian; Kapsali, Eleni; Briasoulis, Evangelos; Kyriakou, Despoina; Hardan, Izhar; Horowitz, Netanel A; Clotilde, Cangialosi; Fabbiano, Francesco; Castagnari, Barbara; Ciceri, Fabio; Musuraca, Gerardo; Deptała, Andrzej; Kłoczko, Janusz; Balea, Marius; Vladareanu, Ana-Maria; Rossiev, Victor; Alegre, Adrián; Encinas, Cristina; Gayoso, Jorge; Pabst, Thomas; Rabin, Neil; Arledge, Sherri; Cabanillas, Fernando; Catlett, Joseph; Chidiac, Tarek; Clarkson, David; Dhodapkar, Madhav; Geils, George; Khan, Cyrus MA; Sahovic, Entezam; Khasawneh, Mohamad; Sehgal, Rajesh; Ballester, Oscar; Levy, Moshe; Fay, Joseph; Liem, Kiem; Lunning, Matthew; Vose, Julie; Faber, Edward; MacFarlane, Donald; Hohl, Raymond; Mahmood, Tariq; Bhaskar, Birbal; Mims, Martha; Oliff, Ira; Paner, Agne; Maciejewski, John; Padmanabhan, Arvinda; Richard, Robert; Sanyal, Amit; Schiller, Gary; Staszewski, Harry; Stevens, Don; Vaughn, Christopher; Windsor, Kevin | |
| Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials | 2013 | Bringhen S;Mateos MV;Zweegman S;Larocca A;Falcone AP;Oriol A;Rossi D;Cavalli M;Wijermans P;Ria R;Offidani M;Lahuerta JJ;Liberati AM;Mina R;Callea V;Schaafsma M;Cerrato C;Marasca R;Franceschini L;Evangelista A;Teruel AI;van der Holt B;Montefusco V;Ciccone G;Boccadoro M;San Miguel J;Sonneveld P;Palumbo A | |
| Aspirin or enoxaparin thromboprophylaxis for newly-diagnosed multiple myeloma patients treated with lenalidomide | 2012 | Larocca A; Cavallo F; Bringhen S; Di Raimondo F; Falanga A; Evangelista A; Cavalli M; Stanevsky A; Corradini P; Pezzati S; Patriarca F; Cavo M; Peccatori J; Catalano L; Carella AM; Cafro AM; Siniscalchi A; Crippa C; Petrucci MT; Ben Yehuda D; Beggiato E; Caravita Di Toritto T; Boccadoro M; Nagler A; Palumbo A | |
| Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study | 2022 | Efficace, Fabio; Gaidano, Gianluca; Petrucci, Maria Teresa; Niscola, Pasquale; Cottone, Francesco; Codeluppi, Katia; Antonioli, Elisabetta; Tafuri, Agostino; Larocca, Alessandra; Potenza, Leonardo; Fozza, Claudio; Pastore, Domenico; Rigolin, Gian Matteo; Offidani, Massimo; Romano, Alessandra; Kyriakou, Charalampia; Cascavilla, Nicola; Gozzetti, Alessandro; Derudas, Daniele; Vignetti, Marco; Cavo, Michele | |
| Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. | 2006 | Larocca A;Piaggio G;Podestà M;Pitto A;Bruno B;Di Grazia C;Gualandi F;Occhini D;Raiola AM;Dominietto A;Bregante S;Lamparelli T;Tedone E;Oneto R;Frassoni F;Van Lint MT;Pogliani E;Bacigalupo A | |
| Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy. | 2014 | Mateos MV;Bringhen S;Richardson PG;Lahuerta JJ;Larocca A;Oriol A;Boccadoro M;García-Sanz R;Di Raimondo F;Esseltine DL;van de Velde H;Desai A;Londhe A;San Miguel JF;Palumbo A | |
| Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: A multicenter, open label phase 1/2 study. | 2012 | Petrucci MT; Levi A; Bringhen S; Scotti S; Gentilini F; Russo S; Siniscalchi A; Larocca A; Grammatico S; Boccadoro M; Foà R; Palumbo A. | |
| Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: a multicenter, open label phase 1/2 study. | 2013 | Petrucci MT;Levi A;Bringhen S;Scotti S;Gentilini F;Russo S;Siniscalchi A;Larocca A;Grammatico S;Boccadoro M;Foà R;Palumbo A | |
| Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study. | 2014 | Morabito F;Bringhen S;Larocca A;Wijermans P;Mateos M V;Gimsing P;Mazzone C;Gottardi D;Omedè P;Zweegman S;Lahuerta J J;Zambello R;Musto P;Magarotto V;Schaafsma M;Oriol A;Juliusson G;Cerrato C;Catalano L;Gentile M;Turel A I;Liberati A M;Cavalli M;Rossi D;Passera R;Rosso S;Beksac M;Cavo M;Waage A;San-Miguel J;Boccadoro M;Sonneveld P;Palumbo A;Offidani M | |
| Bortezomib, Pegylated-Lyposomal-Doxorubicin and Dexamethasone Followed by Melphalan 100 mg/m2 in Elderly Newly Diagnosed Patients: An Interim Analysis. | 2007 | Palumbo A; Avonto I; Patriarca F; Crippa C; Petrucci MT; Rossini F; Corradini P; Liberati AM; Giuliani N; Pescosta N; Falco P; Larocca A; Omedè P; Offidani M; Fanin R; Boccadoro M | |
| Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study | 2020 | Mina R.; Belotti A.; Petrucci M.T.; Zambello R.; Capra A.; Di Lullo G.; Ronconi S.; Pescosta N.; Grasso M.; Monaco F.; Cellini C.; Gobbi M.; Ballanti S.; de Fabritiis P.; Mosca-Siez M.L.; Marchetti M.; Liberati A.M.; Offidani M.; Giuliani N.; Ria R.; Musto P.; Romano A.; Sonneveld P.; Boccadoro M.; Larocca A. | |
| Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial. | 2010 | Palumbo A; Bringhen S; Rossi D; Cavalli M; Larocca A; Ria R; Offidani M; Patriarca F; Nozzoli C; Guglielmelli T; Benevolo G; Callea V; Baldini L; Morabito F; Grasso M; Leonardi G; Rizzo M; Pia Falcone A; Gottardi D; Montefusco V; Musto P; Petrucci MT; Ciccone G; Boccadoro M. | |
| Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival. | 2014 | Palumbo A;Bringhen S;Larocca A;Rossi D;Di Raimondo F;Magarotto V;Patriarca F;Levi A;Benevolo G;Vincelli ID;Grasso M;Franceschini L;Gottardi D;Zambello R;Montefusco V;Falcone AP;Omedé P;Marasca R;Morabito F;Mina R;Guglielmelli T;Nozzoli C;Passera R;Gaidano G;Offidani M;Ria R;Petrucci MT;Musto P;Boccadoro M;Cavo M | |
| Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA) | 2018 | Sara Bringhen, Alberto Milan, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Marco Salvini, Evangelos Terpos, Hartmut Goldschmidt, Michele Cavo, Maria Teresa Petrucci, Heinz Ludwig, Holger W. Auner, Jo Caers, Martin Gramatzki, Mario Boccadoro, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt |